These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16159443)

  • 1. [Clinical significance of protein Z detection in patients with malignant tumors].
    Shang Y; Pan XY; Ding CP; Yang XM; Cai XY; Ding Y; Zhang RL
    Ai Zheng; 2005 Sep; 24(9):1144-7. PubMed ID: 16159443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of protein Z alteration in patients with cardio-cerebral thrombotic diseases].
    Pan XY; Ding CP; Zhong LY; Huang XM; Zhou WX; Guo Y; Yin JZ; Cai XY; Guan ZB; Zhang RL
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):671-4. PubMed ID: 15634572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis.
    Pardos-Gea J; Ordi-Ros J; Serrano S; Balada E; Nicolau I; Vilardell M
    Thromb Res; 2008; 121(6):727-34. PubMed ID: 17869328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
    Yi SZ; Zhang DC; Wang YG; Sun KL
    Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ; Li GM; Huang GP; Li XP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the selected, late phase of angiogenesis factors' concentration in colorectal cancer patients].
    Wieloch M; Swiatkowska M; Libiszewski M; Hedayati M; Drozda R; Kołomecki K
    Pol Merkur Lekarski; 2009 Dec; 27(162):466-9. PubMed ID: 20120708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
    Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
    Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
    Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
    Suzuki H; Ishikawa S; Satoh H; Ishikawa H; Sakai M; Yamamoto T; Onizuka M; Sakakibara Y
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.
    Bugdayci G; Kaplan T; Sezer S; Turhan T; Koca Y; Kocer B; Yildirim E
    Exp Oncol; 2006 Jun; 28(2):169-71. PubMed ID: 16837913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
    Yigit E; Gönüllü G; Yücel I; Turgut M; Erdem D; Cakar B
    Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
    Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
    Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.